Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
https://seekingalpha.com/article/4766032-stevanato-stock-ramping-syringe-demand-buy-confirmed [Seeking Alpha]
Stevanato Group S.p.A. (NYSE: STVN) had its "outperform" rating re-affirmed by analysts at William Blair.
Stevanato Group S.p.A. (NYSE: STVN) had its price target lowered by analysts at UBS Group AG from $24.00 to $23.50. They now have a "neutral" rating on the stock.
Stevanato Group reports Q4 results [Seeking Alpha]